Published steady-state exposure puts 14 mg oral daily closer to a 0.5 mg weekly injection, and even 25 mg oral daily lands near a 0.9 mg weekly injection short of Wegovy 2.4 mg. Switching routes is an exposure change, not a brand swap
This is not a pharmacokinetic effect but rather a physiological one
doi:10.1021/acs.molpharmaceut.1c00689
We review your history and check your B12 level so treatment is based on your actual numbers, not a guess
Theres a black market production, primarily in China, that sends large amounts of these peptides to the United States with the label For research only, says Pinchas Cohen, MD, dean and distinguished professor of gerontology, medicine, and biological sciences at the USC Leonard Davis School of Gerontology, who has discovered several investigational peptides